€12.82
1.08% yesterday
Madrid, Dec 24, 02:00 pm CET
ISIN
ES0157097017
Symbol
ALM

Almirall Stock price

€12.82
+0.24 1.91% 1M
+2.08 19.37% 6M
+4.59 55.68% YTD
+4.67 57.30% 1Y
+3.82 42.44% 3Y
+1.81 16.44% 5Y
-4.96 27.90% 10Y
-1.45 10.17% 20Y
Madrid, Closing price Wed, Dec 24 2025
-0.14 1.08%
ISIN
ES0157097017
Symbol
ALM
Industry

Key metrics

Basic
Market capitalization
€2.8b
Enterprise Value
€2.7b
Net debt
positive
Cash
€376.6m
Shares outstanding
214.8m
Valuation (TTM | estimate)
P/E
49.3 | 36.1
P/S
1.7 | 2.5
EV/Sales
1.7 | 2.4
EV/FCF
91.6
P/B
1.9
Dividends
DPS
€0.18
Yield 1Y | 5Y
1.4% | 1.8%
Growth 1Y | 5Y
0.0% | -1.5%
Payout 1Y | 3Y
368.0% | -461.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€1.6b | €1.1b
EBITDA
€262.2m | €235.0m
EBIT
€113.5m | €88.4m
Net Income
€55.5m | €76.3m
Free Cash Flow
€29.9m
Growth (TTM | estimate)
Revenue
13.6% | 13.6%
EBITDA
5.6% | 24.5%
EBIT
93.3% | 78.2%
Net Income
254.7% | 651.9%
Free Cash Flow
232.4%
Margin (TTM | estimate)
Gross
73.7%
EBITDA
16.5% | 21.0%
EBIT
7.1%
Net
3.5% | 6.8%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
62.1%
Return on Equity
0.7%
ROCE
5.5%
ROIC
-
Debt/Equity
0.2
More
EPS
€0.3
FCF per Share
€0.1
Short interest
-
Employees
2k
Rev per Employee
€490.0k
Show more

Is Almirall a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Almirall Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Almirall forecast:

13x Buy
76%
4x Hold
24%

Analyst Opinions

17 Analysts have issued a Almirall forecast:

Buy
76%
Hold
24%

Financial data from Almirall

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,594 1,594
14% 14%
100%
- Direct Costs 419 419
8% 8%
26%
1,175 1,175
16% 16%
74%
- Selling and Administrative Expenses 521 521
22% 22%
33%
- Research and Development Expense 156 156
15% 15%
10%
262 262
6% 6%
16%
- Depreciation and Amortization 149 149
22% 22%
9%
EBIT (Operating Income) EBIT 113 113
93% 93%
7%
Net Profit 56 56
255% 255%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Almirall directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Carlos Piqué
Employees 2,026
Founded 1995
Website www.almirall.es

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today